Recent biochemical and medical aspects
eBook - PDF

Recent biochemical and medical aspects

International Symposium, February 17–18, 1981, Max-Planck-Institute for Biochemistry, Martinsried/Munich, Germany

  1. 410 pages
  2. English
  3. PDF
  4. Available on iOS & Android
eBook - PDF

Recent biochemical and medical aspects

International Symposium, February 17–18, 1981, Max-Planck-Institute for Biochemistry, Martinsried/Munich, Germany

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Recent biochemical and medical aspects by A. Henschen, H. Graeff, F. Lottspeich in PDF and/or ePUB format, as well as other popular books in Medicina & Biochimica in medicina. We have over one million books available in our catalogue for you to explore.

Information

Publisher
De Gruyter
Year
2019
Print ISBN
9783110085433
eBook ISBN
9783110865325

Table of contents

  1. PREFACE
  2. CONTENTS
  3. I. PHYSICOCHEMICAL ASPECTS
  4. PARACRYSTALLINE STRUCTURE OF NATIVE HUMAN FIBRINOGEN
  5. DETERMINATION OF FIBRIN STRUCTURES BY LIGHT SCATTERING
  6. PARTICULARITIES OF FIBRINOGEN, ROD-LIKE AND BRANCHED FIBRINS
  7. TEMPERATURE EFFECTS ON FIBRIN(OGEN)-FIBRIN SOLUTIONS (Preliminary results)
  8. HYDRODYNAMIC CHARACTERIZATION OF PLASMIN DEGRADATION PRODUCTS PROM HUMAN FIBRINOGEN
  9. THE KINETICS OF FIBRIN FORMATION
  10. II. BIOCHEMICAL ASPECTS
  11. STRUCTURE - FUNCTION - EVOLUTION RELATIONSHIP IN FIBRINOGEN
  12. ARTIFACTUAL HETEROGENEITY OF HUMAN FIBRINOGEN POLYPEPTIDE CHAINS CAUSED BY CARBOXYMETHYLATION
  13. INFLUENCE OF SIALIC ACID ON THE ADULT AND FETAL FIBRINOGEN-FIBRIN TRANSITION
  14. FIBRIN FORMATION IN THE PRESENCE OF TRYPSIN
  15. CHARACTERISATION OF RAT FIBRINOGEN
  16. CHARACTERISATION OF PIG FIBRINOGEN
  17. III. ABNORMAL FIBRINOGENS
  18. ON DYSFIBRINOGENEMIA
  19. DETECTION OF FIBRINOGEN ABNORMALITY IN DYSFIBRINOGENEMIA SPECIAL REPORT ON FIBRINOGEN METZ CHARACTERIZED BY AN AMINO ACID SUBSTITUTION LOCATED AT THE PEPTIDE BOND CLEAVED BY THROMBIN.
  20. BINDING OF CITRATE TO NORMAL FIBRINOGEN AND TO METZ FIBRINOGEN
  21. THE SEARCH FOR MOLECULAR DEFECTS IN ABNORMAL FIBRINOGENS
  22. FIBRINOGEN BERN I: A HEREDITARY FIBRINOGEN VARIANT WITH DEFECTIVE CONFORMATIONAL STABILIZATION BY CALCIUM IONS
  23. CARBOHYDRATE IN ABNORMAL FIBRINOGENS
  24. OBSERVATION ON A NEW VARIANT OF HEREDITARY DYSFIBRINOGENEMIA (HDMBURG I) WITH DELAYED FIBRIN POLYMERIZATION AND WITHOUT CLINICAL ABNORMALITY
  25. IV. FIBRINOPEPTIDE DETERMINATION
  26. FPA-RELEASE IN NORMAL AND ABNORMAL FIBRINOGEN
  27. SIMULTANEOUS CLINICAL EVALUATION OF RADIOIMMUNOASSAYS FOR FIBRINOPEPTIDES AND g-THROMBOGLOBULIN
  28. ANALYSIS OF HUMAN FIBRINOPEPTIDES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY : QUANTITATIVE DETERMINATION AND KINETICS OF RELEASE
  29. V. FIBRINOGEN - FIBRIN COMPLEXES
  30. SOLUBLE FIBRINOGEN-FIBRIN COMPLEXES IN PLASMA AT 37°C
  31. SOLUBLE DES-AA FIBRIN CLEARANCE IN HEALTHY HUMAN SUBJECTS
  32. COMPLEX FORMATION OF SOLUBLE FIBRIN POLYMERS WITH AGAROSECOUPLED FIBRINOGEN AND FIBRIN WITH REGARD TO THEIR MOLECULAR WEIGHT
  33. TEMPERATURE-DEPENDENT REVERSIBLE ASSOCIATION AND DISSOCIATION OF SOLUBLE FIBRIN IN PLASMA
  34. NO COMPLEX FORMATION OF DES-AB FIBRIN WITH FIBRINOGEN INVESTIGATED BY THE HUMMEL AND DREYER PROCEDURE
  35. VI. FIBRIN(OGEN) DEGRADATION AND CROSSLINKED FIBRIN DERIVATIVES
  36. ON THE STRUCTURE OF D-FRAGMENTS OF HUMAN FIBRINOGEN AND FIBRIN
  37. ROLE OF THE C-TERMINUS OF THE FIBRINOGEN y-CHAIN IN FIBRINOGEN Ca<sup>2+</sup> BINDING AND IN FIBRIN POLYMERIZATION
  38. FIBRINOGEN DEGRADATION BY GRANULOCYTE ELASTÄSE AND CATHEPSIN G - GENERATION OF FIBRINOGEN DEGRADATION PRODUCTS WITH ANTICOAGULANT PROPERTIES
  39. A SIMPLE METHOD FOR QUANTIFICATION OF FIBRINOGEN-CHAINS AND EARLY SPLIT-PRODUCTS IN SDS-DISC-ELECTROPHORESIS
  40. HOMOLOGUES OF FIBRIN X OLIGOMERS
  41. FIBRIN FRAGMENTATION BY PLASMIN: MOLECULAR CONSIDERATIONS AND THEIR RELEVANCE TO DIC AND THROMBOSIS
  42. FIBRINOGEN IN LIVER CIRRHOSIS. FIBRIN MONOMER COMPLEXES AND DYSFIBRINOGENAEMIA WITH HIGH SIALIC ACID CONTENT
  43. INFLUENCE OF VARIOUS THROMBIN FORMATION RATES ON THE FIBRIN STABILIZATION PROCESS
  44. SOME OBSERVATION ON CONCENTRATION AND COAGULABILITY OF FIBRINOGEN IN PATIENTS WITH CANCER, WITH AND WITH3UT METASTASIS
  45. VII. BIOLOGICAL EFFECTS OF LOW MOLECULAR WEIGHT PEPTIDES AND INTERACTION WITH OTHER PROTEINS
  46. EFFECTS OF PEPTIDES DERIVED FROM FIBRINOGEN PROTEOLYSIS ON IMMUNEREACTIONS AND TUMOR GROWTH
  47. PLASMIN AND ELASTASE INDUCED FIBRIN DEGRADATION PRODUCTS AND THEIR ACTION ON VASCULAR PERMEABILITY: AN EXPERIMENTAL STUDY
  48. THE EFFECT OF REPEATED INJECTIONS OF FIBRINOPEPTIDES A AND B ON EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS AND GUINEA PIGS
  49. INTERACTION OF FIBRINOGEN WITH ITS PLATELET RECEPTOR REQUIRES THE NATIVE STRUCTURE OF THE MOLECULE AND DIVALENT IONS
  50. STUDIES ON THE BINDING OF TISSUE PLASMINOGEN ACTIVATOR TO FIBRINOGEN AND FIBRIN
  51. FIBRIN BINDING AND TRANSAMIDATION REACTIVE DOMAINS OF FIBRONECTIN
  52. AUTHOR INDEX
  53. SUBJECT INDEX